$0.00
+0.00%Price chart
Feb 19Mar 10Mar 13Mar 18Mar 23Jul 13Aug 28Oct 27
Key dataOct 27, 2026
Open$0.00
From 52W high−98.53%
Volume1000.00
Market cap$5489.22
P/E (TTM)—
P/S (TTM)0.0x
Div yield—
Key dataOct 27, 2026
Open
$0.00
From 52W high
−98.53%
Volume
1000.00
Market cap
$5489.22
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.0x
P/E (TTM)
—
RSI (14)
19.8
MomentumView details →
1D Return
+0.00%
YTD Return
−87.20%
SummaryUpdated Sep 1, 2025
Abpro Holdings Inc (NASDAQ:ABPWW) is a biotechnology company founded in 2004 and headquartered in Woburn, Massachusetts. Originally incorporated as Abpro Corporation, the company changed its name to Abpro Holdings, Inc. in November 2024. The company focuses on developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity conditions using its proprietary DiversImmune platform technology.
Similar companies
Latest newsMore news →
Miles Suk resigned as Chief Executive Officer of Abpro Holdings, Inc., effective August 19, 2026, and M. Fatih Karatas was appointed Interim Chief Executive Officer, effective August 25, 2026.72d agoAbpro Holdings, Inc. was delisted from NASDAQ on May 28, 2026, for failing to comply with Rule 5550(b)(1) regarding minimum equity.154d ago